Mounjaro: What You Should Know About the New Type 2 Diabetes Medicine
Come May 13th, 2022 a new medicine for Type 2 Diabetes known as Mounjaro (Tirzepatide) became available in the market. It is a first-of-its-class…
To take part in the study, participants should:
Qualified participants may be placed on an investigational injection and may be asked to make 15 visits to the study doctor over 1 year. If you qualify, you may receive study-related care and study injection at no charge. You may also receive compensation for travel expenses.
For more study information contact Iowa Diabetes Research at 515-329-5690 or at www.IowaDiabetes.com.
See if you qualify Learn moreCEO and Medical Director
Sub-Investigator
Sub-Investigator
CRC Manager
Clinical Research Coordinator
Clinical Research Coordinator
Clinical Research Coordinator
Clinical Research Coordinator
Clinical Research Coordinator
Have questions? Call us at (515) 329-6800 or email us at info@iowadiabetes.com.